Editorial
The use of therapeutic hypothermia (TH) in clinical medicine is no longer a rarity. Since the modern inception of this technique by Fay in the 1940s, TH has been used for a variety of clinical scenarios. (1,2) TH has gained significant popularity as a brain-protection strategy in victims of sudden cardiac death in whom return of spontaneous circulation (ROSC) has been obtained with coma.
Hypertension remains the “silent killer”. Over 72 million Americans suffer from this condition and it is estimated that as many as 1 billion people worldwide may have it [1]. Critical care clinicians are likely to encounter patients with this malady. Indeed, one percent of patients with essential hypertension (HTN) will develop at some point in their life a hypertensive crisis [2].
In the year 2008, knowledge and technology develop continually in every field of our lives, and, with no exception, in critical care medicine as well. This continuous growth is implicit in our daily activities. We could not imagine our lives today without it. Nowadays, as health care professionals, we surely do not want a fever to last for one week before we can make a diagnosis of typhoid fever for our patients. We can use some simple tests instead and institute prompt therapy.






